Nav: Home

Current Antibodies News and Events

Current Antibodies News and Events, Antibodies News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
When developing vaccines against COVID-19, 'fast is slow, and slow is fast'
Bypassing clinical trials for a potential SARS-CoV-2 vaccine would be ''catastrophic,'' says Science Advances deputy editor Douglas Green in this Editorial. (2020-05-22)
A 'switch' that turns autoimmunity drugs into powerful anti-cancer treatments
Scientists from the Antibody and Vaccine group at the University of Southampton have discovered a way to transform antibody drugs previously developed to treat autoimmunity into antibodies with powerful anti-cancer activity through a simple molecular 'switch'. (2020-05-21)
New technology can detect anti-virus antibody in 20 minutes
Researchers have succeeded in detecting anti-avian influenza virus antibody in blood serum within 20 minutes, using a portable analyzer they have developed to conduct rapid on-site bio tests. (2020-05-21)
New insight into allergies could improve diagnosis and treatment
A study led by investigators at Massachusetts General Hospital point to a potential marker of these conditions and a new therapeutic strategy. (2020-05-20)
X-ray experiments zero in on COVID-19 antibodies
An antibody derived from a SARS survivor in 2003 appears to effectively neutralize the coronavirus that causes COVID-19, opening the door for speedy development of a targeted treatment. (2020-05-19)
COVID-19 antibody testing needn't be perfect to guide public health and policy decisions
While it's too soon to use COVID-19 antibody testing to issue 'immunity passports', antibody tests that are available today are good enough to inform decisions about public health and relaxing social distancing interventions, says an international group of infectious disease and public health experts in Science Immunology today. (2020-05-19)
Novel tool developed to diagnose and monitor autoimmune disorders
Russian researchers have developed a novel method for diagnosing and monitoring autoimmune disorders. (2020-05-19)
Antibody neutralizes SARS and COVID-19 coronaviruses
An antibody first identified in a blood sample from a patient who recovered from Severe Acute Respiratory Syndrome in 2003 inhibits related coronaviruses, including the one that causes COVID-19. (2020-05-18)
Coronaviruses do not readily induce cross-protective antibody responses
Patients infected with either severe acute respiratory syndrome coronavirus (SARS-CoV) or SARS-CoV-2 produce antibodies that bind to the other coronavirus, but the cross-reactive antibodies are not cross protective, at least in cell-culture experiments, researchers report May 17 in the journal Cell Reports. (2020-05-18)
The malaria parasite P. vivax can remain in the spleen upon expression of certain proteins
The malaria parasite Plasmodium vivax can adhere to human spleen cells through the expression of so-called variant proteins. (2020-05-18)
Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity. (2020-05-18)
Viral infection: Early indicators of vaccine efficacy
Ludwig-Maximilians-Universität (LMU) in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of vaccine efficacy than conventional tests for neutralizing antibodies. (2020-05-15)
IU School of Medicine study tracks COVID-19 spread in pediatric dialysis unit
As COVID-19 continues its sweep around the globe, dialysis units have continued to be hotspots for the virus' spread. (2020-05-14)
Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines. (2020-05-14)
Twin antibodies show neutralizing activity against SARS-CoV-2
Scientists have identified a pair of neutralizing antibodies - isolated from a patient who recovered from COVID-19 - that bind to the glycoprotein spike of the SARS-CoV-2 virus, blocking the spike's ability to bind to the human ACE2 receptor and mediate viral entry into host cells. (2020-05-13)
SARS-CoV-2: A new song recalls an old melody
Important lessons learned from the Severe Acute Respiratory Syndrome (SARS) outbreak of 2002-2003 could inform and guide vaccine design for COVID-19 according to University of Melbourne Professor Kanta Subbarao, Director of the WHO Centre for Reference and Research on Influenza at the Doherty Institute. (2020-05-13)
Passive immunization may slow down SARS-CoV-2 and boost immunity in patients, buying time
The worldwide COVID-19 pandemic has infected more than 4 million people and killed close to 280,000.1 Finding a vaccine has become a global public health priority. (2020-05-12)
New HIV vaccine strategy strengthens, lengthens immunity in primates
Investigators at the Stanford University School of Medicine and several other institutions have shown that a new type of vaccination can substantially enhance and sustain protection from HIV. (2020-05-11)
Blood test a potential new tool for controlling infections
A new technique could provide vital information about a community's immunity to infectious diseases including malaria and COVID-19. (2020-05-11)
Towards antibodies against COVID-19
The lab of Xavier Saelens (VIB-UGent Center for Medical Biotechnology) announces the isolation and characterization of a unique antibody that can bind to the virus that causes COVID-19 (SARS-CoV-2). (2020-05-06)
Inactivated vaccine candidate protects macaques from SARS-CoV-2 infection
In mice, rats, and nonhuman primates, a newly developed SARS-CoV-2 virus vaccine candidate induced antibodies that neutralized several different SARS-CoV-2 strains. (2020-05-06)
Researchers report discovery of antibody that blocks infection by the SARS-CoV-2 in cells
Researchers at Utrecht University, Erasmus Medical Center and Harbour BioMed (HBM) today reported that they have identified a fully human monoclonal antibody that prevents the SARS-CoV-2 (COVID-19) virus from infecting cultured cells.The discovery, published online today in Nature Communications, is an initial step towards developing a fully human antibody to treat or prevent the respiratory disease COVID-19 caused by the novel coronavirus SARS-CoV-2. (2020-05-04)
Mapping glycan composition on the SARS-CoV-2 spike protein to inform vaccine design
Using high-resolution mass spectrometry, researchers have mapped glycan-processing states of the spike protein complex that allows the SARS-CoV-2 virus to infect human cells - finding that SARS-CoV-2 S glycans differ from typical host glycan processing, which may have implications in vaccine design. (2020-05-04)
Recently recovered COVID-19 patients produce varying virus-specific antibodies
Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, suggests a study published on May 3rd in the journal Immunity, but the responses of different patients are not all the same. (2020-05-04)
Understanding the initial immune response after dengue virus infection
This study sheds new light on the body's initial response to dengue virus infection, describing the molecular diversity and specificity of the antibody response. (2020-05-01)
Cracking the Lyme disease code
The next time a tick feeds on you, Washington State University researchers hope to make sure persistent arthritis caused by Lyme disease doesn't linger for a lifetime. (2020-04-30)
Improving immunotherapy for cancer
One of the reasons why cancer develops is because regulatory cells inhibit the body's immune defense. (2020-04-29)
Sensitive new test detects antibodies against SARS-CoV-2 in only 10 minutes
As the COVID-19 curve shows signs of flattening in the U.S. and elsewhere, public health officials are trying to grasp just how many people have been infected. (2020-04-29)
Antibodies from llamas could help in fight against COVID-19
Initial tests of a new candidate antibody treatment for COVID-19 indicate that it blocks viruses that display the SARS-CoV-2 spike protein from infecting cells in culture. (2020-04-29)
Synthetic antibodies built with bacterial superglue could help fight emerging viruses
Synthetic antibodies constructed using bacterial superglue can neutralise potentially lethal viruses, according to a study published on April 21 in eLife. (2020-04-28)
New findings on hepatitis C in infants can lead to improved treatments
Only about 5% of the babies born to mothers with hepatitis C are themselves infected by the disease. (2020-04-27)
New staining technique visualizes whole organs and bodies
A RIKEN research team in Japan has established an optimized three-dimensional (3D) tissue-staining and observation technique based on existing tissue clearing technology. (2020-04-27)
Sensor detects biomarker of early-stage multiple sclerosis
Diagnostic strategy developed by Brazilian researchers can also be used to distinguish MS from neuromyelitis optica, another demyelinating disorder. (2020-04-23)
Research reveals a new malaria vaccine candidate
In a study that could lead to a new vaccine against malaria, researchers have found antibodies that trigger a 'kill switch' in malarial cells, causing them to self-destruct. (2020-04-22)
A novel method to precisely deliver therapeutics inside the body
A new way to deliver therapeutic proteins inside the body uses an acoustically sensitive carrier to encapsulate the proteins and ultrasound to image and guide the package to the exact location required, according to Penn State researchers. (2020-04-22)
Researchers uncover mechanisms of protective antibody response during Marburg infection
A detailed study of the monoclonal antibodies from a person who survived a Marburg infection led researchers to identify novel mechanisms that contribute protection against the disease, according to the latest findings of a collaborative team led by The University of Texas Medical Branch at Galveston and Vanderbilt University Medical Center. (2020-04-21)
Nasal smear as an allergy screening test
In the world of allergy diagnostics, the familiar blood samples and unpleasant skin prick procedures for testing allergen tolerance may soon be a thing of the past. (2020-04-17)
'Directing' evolution to identify potential drugs earlier in discovery
Scientists have developed a technique that could significantly reduce the time of discovering potential new antibody-based drugs to treat disease. (2020-04-14)
UofL researchers describe possible mechanism for link between obesity and breast cancer
It is widely accepted that higher levels of body fat increase the risk of developing breast cancer, as well as other cancers. (2020-04-13)
Is autoimmunity on the rise?
A study published in Arthritis & Rheumatology provides evidence that the prevalence of autoimmunity -- when the immune system goes awry and attacks the body itself -- has increased in the United States in recent years. (2020-04-08)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.